EMCOR Group, Inc. (EME)

Stalwart

FairStock Score: 58/100 — STEADY

Key Financials

Current Price$913.11
Market Cap$32.2B
P/E Ratio30.69
ROE39.23%
Dividend Yield0.16%
SectorIndustrials

Strengths

Concerns

AI Analysis

EMCOR presents a classic case of a quality business trading at an unjustifiable price. Let me be direct: at $719 per share with a Graham Number of $134, we're looking at a 435% negative margin of safety. This is not a value opportunity; it's a speculation. That said, the underlying business quality deserves respect. With $4.5B in quarterly revenue and a 9.63% net margin, EMCOR demonstrates operational excellence. The 38.49% ROE is exceptional—far above the cost of capital—and their 11.60% ROCE suggests genuine competitive advantages in essential infrastructure services. Their $991.1M in free cash flow generation proves the earnings quality. The balance sheet is fortress-like with only 0.13 debt-to-equity ratio. However, valuation destroys opportunity. An EV/EBITDA of 48.99x is absurd for an engineering and construction company. The stock has nearly tripled from its 52-week low of $321, suggesting momentum-driven pricing rather than fundamental revaluation. A 1.5% free cash flow yield is pitiful for equity investors. The Piotroski score of 7/9 indicates solid financials, and the Altman Z-score of 5.12 shows zero bankruptcy risk. Yet none of this justifies the multiple being paid. I've built my career on buying quality businesses at reasonable prices. EMCOR is quality at an unreasonable price. The FairStock score of 49/100 confirms this is fairly valued at best, overvalued at worst. I'll watch from the sidelines until reality meets valuation.

Bull Case

EMCOR's best-in-class ROE and ROCE reflect durable competitive advantages in critical infrastructure that justify premium multiples as AI and energy transition drive sustained capex cycles. Continued margin expansion and international growth could support higher valuations if execution remains flawless.

Bear Case

The euphoric valuation will compress sharply when growth slows or construction cycle turns, and a 1.5% FCF yield offers inadequate return for patient capital. Regression to historical sector multiples would cut the stock price in half.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer